July 24, 2017 article Open access Melanoma subtypes demonstrate distinct PD-L1 expression profiles Laboratory Investigation DOI: 10.1038/labinvest.2017.64 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 4 stored of 213 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Tumour progression shows decrease in PD‐L1 expression in matched metastases/primary uveal melanomas 2025 Acta Ophthalmologica article Medicine Ocular Oncology and Treatments Open access 0 citations Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma 2024 JCI Insight article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent 25 citations PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma 2023 Investigative Ophthalmology & Visual Science article Medicine Ocular Oncology and Treatments Open access 27 citations Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial 2022 Trials article Medicine Ocular Oncology and Treatments Open access 23 citations 4 results References 0